Kidney disease in antiretroviralnaïve HIV-positive adults with high CD4: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral...

Por Achhra, AC, Mocroft, A, Ross, MJ, Ryom, L, Lucas, GM, Furrer, H, Neuhaus, J, Somboonwit, C, Kelly, M, Gatell, JM, Wyatt, CM
Publicado no HIV Med (2015)

Loading dendritic cells from HIV-1 infected patients with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses

Por Climent, N, Munier, S, Piqué, N, García, F, Pavot, V, León, A, Primard, C, Miralles, L, Rovira, C, Casanova, V, McCormick, P, Gatell, JM, Verrier, B, Gallart, T
Publicado em 2012

P18-07. <it>Ex vivo </it>production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)

Por Gallart T, Miró JM, Zamora L, Martinez-Picado J, Almela M, Pumarola T, Dalmau J, Maite G, León A, García F, Nieto S, Hurtado C, Climent N, Gil C, Gatell JM
Publicado em 2009-10-01

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)

Por Gil, C, Climent, N, Hurtado, C, Nieto, S, García, F, León, A, Maite, G, Dalmau, J, Pumarola, T, Almela, M, Martinez-Picado, J, Zamora, L, Miró, JM, Gallart, T, Gatell, JM
Publicado em 2009